EFFECTS OF BLOCKADE OF 5-HT2 RECEPTORS AND ACTIVATION OF 5-HT1A RECEPTORS ON THE EXPLORATORY ACTIVITY OF RATS IN THE ELEVATED PLUS-MAZE

被引:56
作者
MOTTA, V [1 ]
MAISONNETTE, S [1 ]
MORATO, S [1 ]
CASTRECHINI, P [1 ]
BRANDAO, ML [1 ]
机构
[1] UNIV SAO PAULO,FAC FILOSOFIA CIENCIAS & LETRAS RIBEIRAO PRETO,PSICOBIOL LAB,BR-14049 RIBEIRAO PRETO,SP,BRAZIL
关键词
5-HT1A RECEPTORS; 5-HT2; RECEPTORS; ANXIETY; GEPIRONE; KETANSERIN; PLUS-MAZE TEST;
D O I
10.1007/BF02244978
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acute administration of gepirone, a 5-HT1A agonist, caused a dose dependent (1-10 mg/kg, IP) reduction in the locomotor activity (open and closed arms) of rats tested in the elevated plus-maze. However, rats housed in individual cages and submitted to chronic treatment with gepirone (10 mg/kg PO) showed a marked increase in the percentages of number and time spent in the open arms as compared to controls. These results are compatible with the idea that the antiaversive effect due to long-term treatment with 5-HT1A agonists is the result of a progressive desensitization of the somatodendritic 5-HT autoreceptor with the consequent recovery of firing rate of 5-HT neurons along with an activation of normosensitive postsynaptic 5-HT neurons. Ketanserin caused a biphasic effects on the exploratory behavior of rats in the plus-maze. The lower dose (0.5 mg/kg) decreased the aversion to the open arms and the higher dose (1.0 mg/kg) caused an unspecific decrease in the overall activity of the animals. Ketanserin is supposed to have antagonistic action on 5-HT2 and on alpha-adrenergic receptors. As prazosin (0.5-1.0 mg/kg), an alpha-adrenergic receptor blocker, did not present any significant effect in the present work it is suggested that the effects of the lower dose of ketanserin was due to its high antagonistic action on 5-HT2 receptors.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 27 条
  • [1] BEHAVIORAL EVIDENCE FOR A FUNCTIONAL INTERACTION BETWEEN CENTRAL 5-HT2-RECEPTOR AND 5-HT1A-RECEPTOR
    BACKUS, LI
    SHARP, T
    GRAHAMESMITH, DG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1990, 100 (04) : 793 - 799
  • [2] MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN
    BLIER, P
    DEMONTIGNY, C
    [J]. SYNAPSE, 1987, 1 (05) : 470 - 480
  • [3] Blier P, 1987, J CLIN PSYCHOPHARM S, V7, p24S
  • [4] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [5] CELEUMANS DLS, 1985, PHARMACOPSYCHIATRY, V18, P303
  • [6] BEHAVIORAL AND 5-HT ANTAGONIST EFFECTS OF RITANSERIN - A PURE AND SELECTIVE ANTAGONIST OF LSD DISCRIMINATION IN RAT
    COLPAERT, FC
    MEERT, TF
    NIEMEGEERS, CJE
    JANSSEN, PAJ
    [J]. PSYCHOPHARMACOLOGY, 1985, 86 (1-2) : 45 - 54
  • [7] CRITCHLEY MAE, 1987, PSYCHOPHARMACOLOGY, V93, P502
  • [8] CSANALOSI I, 1987, J CLIN PSYCHOPHARM, V7, P31
  • [9] DEAKIN JFW, 1989, BEHAVIOURAL PHARM 5H, P179
  • [10] SEROTONERGIC MECHANISMS IN THE BEHAVIORAL-EFFECTS OF BUSPIRONE AND GEPIRONE
    EISON, AS
    EISON, MS
    STANLEY, M
    RIBLET, LA
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (03) : 701 - 707